Reporting vaccine-associated paralytic poliomyelitis: concordance between the CDC and the National Vaccine Injury Compensation Program.
This paper compares cases of paralytic poliomyelitis reported to the systems operated by the National Vaccine Injury Compensation Program and the Centers for Disease Control and Prevention (CDC) for reporting of adverse events associated with vaccination. Of the 118 cases of vaccine-associated paralytic poliomyelitis determined by either system, 18 were reported initially only to the compensation program, 50 only to the CDC, and 50 to both. The annual incidence of vaccine-associated paralytic poliomyelitis determined from data from both systems varied from 6 to 13 cases (mean = 9.1) a year, with an increase of 1.4 cases a year when initial reports only to the compensation program are included. Thus, the compensation program provides important supplemental incidence data.
Weibel
R E
RE
National Vaccine Injury Compensation Program, Health Resources and Services Administration, Rockville, Md 20857, USA.
Benor
D E
DE
D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010243:Paralysis / Q000139:chemically induced / Q000453:epidemiology; D011051:Poliomyelitis / Q000139:chemically induced* / Q000453:epidemiology*; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*; D011159:Population Surveillance; D014481:United States
D011055:Poliovirus Vaccine, Oral